Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $150.34 +0.56%
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
- Trio-Tech wins $4.7M automotive semiconductor burn-in contract
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
